Degree and Direction of Change of Body Weight in Cardiac Rehabilitation and Impact on Exercise Capacity and Cardiac Risk Factors

The American Journal of Cardiology
Pallavi S GomadamKillian C Robinson

Abstract

Cardiac rehabilitation (CR) improves functional capacity and reduces mortality in patients with cardiovascular disease. It also improves cardiovascular risk factors and aids in weight reduction. Because of the increase in morbidly obese patients with cardiovascular disease, the prevalence of obesity and patterns of weight change in those undergoing CR merit fresh study. We studied 1,320 participants in a 12-week CR program at our academic medical center. We compared 5 categories: 69 class III obese (body mass index [BMI] ≥40) patients, 128 class II obese patients (BMI 35.0 to 39.9), 318 class I obese patients (BMI 30.0 to 34.9), 487 overweight patients (BMI 25.0 to 29.9), and 318 normal weight patients (BMI 18.5 to 24.9). Exercise capacity in METs, weight, blood pressure, and fasting lipid profile were measured before and after CR. Overall, 131 patients gained weight, 827 had no significant weight change, and 363 lost weight (176 lost 3% to 5% of their baseline weight, 161 lost 5% to 10%, and 26 lost >10%). Exercise capacity, blood pressure, and low-density lipoprotein cholesterol improved in all patients. Class III obese patients had the smallest improvement in peak METs (p <0.001), but the greatest weight loss. Patients who l...Continue Reading

References

Mar 1, 1997·The American Journal of Cardiology·C J Lavie, R V Milani
Sep 22, 2001·The New England Journal of Medicine·P A Ades
Aug 18, 2009·The American Journal of Medicine·Carl J LavieHector O Ventura
Jul 9, 2013·The American Journal of Cardiology·Hardik MehtaKillian Robinson
Jan 21, 2014·Progress in Cardiovascular Diseases·Alban De SchutterRichard V Milani
Jan 22, 2014·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 13, 2014·Progress in Cardiovascular Diseases·Arthur R MenezesMark A Williams
Mar 13, 2014·Progress in Cardiovascular Diseases·Sherry L GraceAlexander M Clark
Sep 14, 2014·Progress in Cardiovascular Diseases·Arthur R MenezesBarry A Franklin

❮ Previous
Next ❯

Citations

Jun 30, 2019·Current Treatment Options in Cardiovascular Medicine·Maeve Jones-O'Connor, Pradeep Natarajan
Apr 9, 2019·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Tasuku TeradaJennifer L Reed
Oct 25, 2020·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·G ValentinoM Acevedo
Mar 2, 2021·Journal of Cardiopulmonary Rehabilitation and Prevention·Kariann R DrwalRamzi N El Accaoui
May 4, 2021·International Journal of Cardiology·Jacqueline A WilkinsonPatrick Doherty
Jun 26, 2021·Journal of the American Medical Directors Association·Pallav DekaElena Marques-Sule
Aug 31, 2021·Journal of Cardiopulmonary Rehabilitation and Prevention·Philip A Ades, Patrick D Savage
Jun 6, 2021·Physical Therapy·Iris den UijlRita J G van den Berg-Emons

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.